Study guide

4.1 Aerosol Physics & Delivery Devices

NBRC RRT-NPS Neonatal/Pediatric Specialist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neonatal and Pediatric Patient Assessment

1.1 Maternal, Obstetric & Perinatal History 1.2 Fetal Surveillance & Antepartum Diagnostics 1.3 Gestational Age & Baseline Neonatal Examination 1.4 Apgar, Respiratory Distress & Thoracic Assessment 1.5 Pediatric Assessment Triangle & Vital Signs 1.6 Neurologic Assessment, Respiratory Failure & Triage

2 Chapter 2: Diagnostic Evaluation & Gas Exchange Monitoring

2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring 2.2 Capnography, Waveforms & Dead-Space Evaluation 2.3 Arterial & Capillary Blood-Gas Sampling 2.4 Umbilical Lines, Acid-Base & Laboratory Evaluation 2.5 Chest Imaging & Airway Radiography 2.6 Pulmonary Function, Bronchoscopy & Specimen Diagnostics

3 Chapter 3: Airway Management & Secretion Clearance

3.1 Pediatric Airway Anatomy & ETT Sizing 3.2 Cuffed Airways, Intubation & Difficult-Airway Management 3.3 Tracheostomy Devices & Routine Care 3.4 Tracheostomy Emergencies, Speaking & Decannulation 3.5 Airway Suctioning Technique & Safety 3.6 Airway Clearance, Home Care & Discharge Planning

4 Chapter 4: Pharmacology & Medical Gas Therapy

4.1 Aerosol Physics & Delivery Devices 4.2 Respiratory & Systemic Pharmacology 4.3 Oxygen Interfaces & Delivery Systems 4.4 Oxygen Blenders, Targets & Toxicity 4.5 HFNC Physiology, Sizing & Flow 4.6 HFNC Indications, Monitoring & Escalation

5 Chapter 5: Shared Neonatal & Pediatric Pulmonary Disorders

5.1 Neonatal RDS Pathophysiology & Management 5.2 TTN, Pneumonia & the Neonatal Differential 5.3 Meconium Aspiration & PPHN 5.4 BPD, Apnea & Chronic Neonatal Lung Disease 5.5 Bronchiolitis, Croup & Epiglottitis 5.6 Asthma, Cystic Fibrosis & Foreign-Body Aspiration

6 Chapter 6: Resuscitation, Emergency Protocols & Patient Safety

6.1 NRP Cord Management, Initial Steps & Ventilation 6.2 NRP Corrective Steps, Compressions & Medications 6.3 PALS Assessment, CPR & Cardiac Arrest 6.4 PALS Dysrhythmia & Shock Management 6.5 Neonatal & Pediatric Transport 6.6 Patient Safety, Teamwork & Family-Centered Care

7 Chapter 7: Noninvasive & Conventional Mechanical Ventilation

7.1 Bubble CPAP & Neonatal NIV 7.2 Pediatric NIV, Interfaces & Failure Recognition 7.3 Conventional Ventilation Physics & Modes 7.4 Initial Settings & ABG-Guided Titration 7.5 Ventilator Scalars & Loops 7.6 Ventilator Dyssynchrony & Troubleshooting 7.7 Weaning Readiness & Spontaneous Breathing Trials 7.8 Extubation & Post-Extubation Airway Risk

8 Chapter 8: High-Frequency Ventilation & Advanced Modes

8.1 HFOV Mechanics & Gas Transport 8.2 HFOV Controls & Clinical Management 8.3 HFJV Circuit & Controls 8.4 HFJV Servo Pressure & Clinical Indications 8.5 NAVA, Edi & Proportional Support 8.6 APRV in Pediatric Respiratory Failure

9 Chapter 9: Specialty Inhaled Gases & Exogenous Surfactant Therapy

9.1 Inhaled Nitric Oxide: Mechanism, Indications & Dose 9.2 Inhaled Nitric Oxide: Toxicity, Monitoring & Weaning 9.3 Heliox Physics & Delivery 9.4 Volatile Anesthetic & Subambient Gas Therapy 9.5 Surfactant Biology, Products & Dosing 9.6 Surfactant Administration & Response

10 Chapter 10: Pediatric ARDS & Parenchymal Critical Illness

10.1 PALICC-2 Diagnosis & Severity 10.2 PALICC-2 NIV & Possible PARDS 10.3 PARDS Lung-Protective Ventilation 10.4 PARDS Refractory Hypoxemia & Adjuncts 10.5 PIE & Pneumothorax Recognition 10.6 Thoracic Decompression & Chest Drains

11 Chapter 11: Congenital Heart Disease & Hemodynamic Management

11.1 Left-to-Right Shunts & Qp/Qs Physiology 11.2 Acyanotic Lesions & Respiratory Management 11.3 Cyanotic Lesions & the Five Ts 11.4 Ductal Dependence, PGE1 & the Hyperoxia Test 11.5 Single-Ventricle Physiology & Staged Palliation 11.6 Gas Balancing, Hemodynamics & NIRS

12 Chapter 12: Advanced Critical Care: ECMO, Neurotrauma & Palliative Care

12.1 ECMO Candidacy & Modality 12.2 ECMO Circuit, Lung Rest & Anticoagulation 12.3 Neurotrauma, ICP & Ventilation 12.4 Neonatal Therapeutic Hypothermia & Respiratory Care 12.5 Death by Neurologic Criteria: Examination & Apnea Testing 12.6 DNC Timing, Ancillary Testing, Palliation & Donation

4.1 Aerosol Physics & Delivery Devices

Key Takeaways Explain This Topic AI

Particles in the roughly 1-5 micrometer aerodynamic range form the respirable fraction; smaller particles tend to reach more distal lung regions, while larger particles increasingly deposit in the upper and conducting airways.

Infant aerosol delivery is often inefficient because of nasal filtration, small tidal volumes, short inspiratory time, distress, leaks, and interface dead space. Do not apply one nominal-dose deposition percentage to every device or patient.

A pMDI with an age-appropriate valved holding chamber is efficient for many children; nebulizers remain useful in selected patients. A calm breathing pattern, correct assembly, and a sealed mask or mouthpiece are central to either method.

Last updated: September 2026

4.1 Aerosol Physics & Delivery Devices

Aerosol medicine in neonatal and pediatric practice presents unique aerodynamic and developmental challenges. Infants and children are not miniature adults; their airway geometry, ventilatory patterns, and clinical tolerance radically alter the fraction of an aerosolized drug that reaches the lower respiratory tract. Mastering delivery physics, interface selection, and pharmacological agents is essential for the Neonatal/Pediatric Specialist.

Aerosol Physics & Pediatric Deposition Mechanics

Aerosol deposition within the human respiratory tract is governed by three primary physical mechanisms:

Inertial Impaction: Occurs when particles possess excessive momentum to negotiate curves in the airway and collide with mucosal surfaces. This mechanism predominates in particles with a Mass Median Aerodynamic Diameter (MMAD) > 5 μ m > 5\text{ }\mu\text{m} > 5 μ m , occurring primarily in the nasopharynx, oropharynx, and bifurcations of the large conducting airways where gas velocity is highest.

Gravitational Sedimentation: Occurs when aerosol droplets settle out of suspension under the influence of gravity during low-velocity airflow. This mechanism predominates for particles with an MMAD of 1 to 5 μ m 1\text{ to }5\text{ }\mu\text{m} 1 to 5 μ m within the smaller conducting airways and terminal bronchioles. Sedimentation is highly dependent on airway residence time and is enhanced by an inspiratory breath-hold.

Brownian Diffusion: The primary mechanism for ultra-fine particles ( MMAD < 0.5 to 1.0 μ m < 0.5\text{ to }1.0\text{ }\mu\text{m} < 0.5 to 1.0 μ m ) in the distal alveolar spaces where bulk gas flow ceases. Sub-micron particles undergo random collisions with gas molecules. However, particles < 0.5 μ m < 0.5\text{ }\mu\text{m} < 0.5 μ m frequently remain suspended in gas and are exhaled before contacting alveolar walls.

Optimal Particle Sizing for Neonates and Children

The respirable fraction is commonly described as particles around 1 to 5 μ m 1\text{ to }5\text{ }\mu\text{m} 1 to 5 μ m MMAD , with deposition shifting by size, airway geometry, inhalation pattern, formulation, and device:

Particles > 5 μ m > 5\text{ }\mu\text{m} > 5 μ m : Increasingly deposit in the mouth, nose, and larger conducting airways by impaction.

Particles 3 to 5 μ m 3\text{ to }5\text{ }\mu\text{m} 3 to 5 μ m : Favor central and conducting-airway deposition.

Particles 1 to 3 μ m 1\text{ to }3\text{ }\mu\text{m} 1 to 3 μ m : More readily penetrate toward smaller bronchi and distal regions, although submicron particles may remain suspended and be exhaled.

Developmental Barriers to Pediatric Aerosol Deposition

Infants receive a dramatically smaller percentage of the nominal nebulized dose than adults due to distinct physiological factors:

Obligate Nasal Breathing: Up to 4 to 6 months of age, infants breathe preferentially through the nose. The tortuous nasal turbinates and narrow passages act as high-efficiency filters that remove up to 50% of aerosol particles before they reach the trachea.

Low Tidal Volumes and High Deadspace: Neonatal tidal volumes ( V T V_T V T ​ ) are small ( 4 to 6 mL/kg 4\text{ to }6\text{ mL/kg} 4 to 6 mL/kg ), while the ratio of deadspace to tidal volume ( V D / V T V_D / V_T V D ​ / V T ​ ) is high. Only a small volume of aerosol-bearing gas enters the lungs with each breath.

Rapid Respiratory Rates & Short Inspiratory Times ( T I T_I T I ​ ): Neonates breathe at 30 to 60 breaths/min with T I T_I T I ​ as brief as 0.3 to 0.5 seconds 0.3\text{ to }0.5\text{ seconds} 0.3 to 0.5 seconds . This brief inspiratory phase limits the time available for sedimentation, while rapid flow increases turbulent impaction at the glottis.

Small Airway Diameters: By Poiseuille's law, resistance is inversely proportional to the fourth power of the radius ( R ∝ 1 / r 4 R \propto 1/r^4 R ∝ 1/ r 4 ). Narrow infant airways promote premature impaction of droplets in proximal branches.

Infant lower-airway deposition is often a small fraction of the nominal dose, but the fraction changes substantially with the aerosol generator, interface, seal, breathing pattern, airway, and study method. Interpret device data rather than memorizing one percentage.

Aerosol Delivery Devices & Clinical Interfaces

Interface fit, aerosol generator, technique, breathing pattern, airway caliber, and adherence all influence pediatric aerosol delivery. +------------------------------------------------------------------------------------------------+

  • | AEROSOL GENERATOR COMPARISON |
  • +-----------------------+-------------------------+---------------------+------------------------+
  • | Device Type | Operating Mechanism | Residual Dead Volume| Impact on Mechanical |
  • | | | | Ventilation |
  • +-----------------------+-------------------------+---------------------+------------------------+
  • | pMDI + Valved Holding | Metered dose canister; | Negligible | In-line chamber; |
  • | Chamber (VHC) | propellant vaporization | | zero added flow |
  • +-----------------------+-------------------------+---------------------+------------------------+
  • | Small Volume Jet | Pneumatic jet sheer; | High (0.5–1.0 mL) | Adds 6–8 L/min flow; |
  • | Nebulizer (SVN) | continuous flow gas | | alters VT and triggers |
  • +-----------------------+-------------------------+---------------------+------------------------+
  • | Vibrating Mesh | Piezoelectric aperture | Minimal (< 0.1 mL) | Zero added flow; |
  • | Nebulizer (VMN) | plate (100–130 kHz) | | preserves vent settings|
  • +-----------------------+-------------------------+---------------------+------------------------+
  • 1. Pressurized Metered-Dose Inhaler (pMDI) with Valved Holding Chamber (VHC)

A pMDI with a valved holding chamber and an age-appropriate snug mask or mouthpiece is an efficient, widely recommended bronchodilator-delivery method for many infants and children. Nebulizers remain appropriate in selected patients and settings; technique and cooperation often matter more than the device label.

Mechanism of VHC: The holding chamber provides physical distance between the canister nozzle and the patient's mouth, allowing high-velocity propellant to evaporate, slowing the aerosol plume velocity, and reducing MMAD into the respirable range. The one-way inspiratory valve retains the aerosol cloud within the chamber until the child inhales, eliminating the requirement for hand-breath coordination.

Mask seal: A leak around a pediatric mask can sharply reduce inhaled dose. Use the manufacturer's fit guidance, minimize dead space, and observe the valve or device indicator when available.

The crying child: Crying produces an unfavorable inspiratory pattern and usually reduces lung delivery. Calm the child and use quiet tidal breathing when feasible; do not assume an exact percentage loss for every device.

Blow-by technique: Dose falls rapidly as the interface moves away from the face, so blow-by is unreliable. Prefer a sealed, age-appropriate mask or mouthpiece unless a specific device has validated a different setup.

2. Vibrating Mesh Nebulizers (VMN)

Vibrating mesh nebulizers utilize a piezoelectric element vibrating at high frequency ( 100 to 130 kHz 100\text{ to }130\text{ kHz} 100 to 130 kHz ) to pump liquid medication through thousands of laser-drilled micro-apertures in a dome-shaped aperture plate:

Aerosol Characteristics: Generates uniform droplets with an MMAD of 1 to 3 μ m 1\text{ to }3\text{ }\mu\text{m} 1 to 3 μ m and high output rates ( > 0.2 to 0.4 mL/min > 0.2\text{ to }0.4\text{ mL/min} > 0.2 to 0.4 mL/min ).

Low residual volume: Vibrating-mesh devices generally retain less medication than many jet nebulizers, though residual volume and emitted dose are device- and formulation-specific.

Role in mechanical ventilation: A VMN does not add pneumatic driving flow. Placement strongly affects delivered dose and must follow the ventilator, nebulizer, humidifier, and medication instructions; circuit position is not interchangeable across systems.

3. Small Volume Jet Nebulizers (SVN)

Pneumatic jet nebulizers use a specified compressed-gas source and flow through a narrow capillary to draw liquid upward and break it against a baffle. Many small-volume devices operate near 6-8 L/min, but the required pressure and flow come from the device labeling.

Dead Volume (Residual Volume): Jet nebulizers retain 0.5 to 1.0 mL 0.5\text{ to }1.0\text{ mL} 0.5 to 1.0 mL of liquid dead volume trapped inside the cup. Because a standard 2.5 mg 2.5\text{ mg} 2.5 mg albuterol unit dose contains only 3.0 mL 3.0\text{ mL} 3.0 mL of fluid, a residual volume of 1.0 mL 1.0\text{ mL} 1.0 mL traps 33 % 33\% 33% of the drug. Any added diluent, fill volume, and run time must follow the medication and nebulizer instructions; adding saline is not appropriate for every formulation or device.

Mechanical-ventilation interaction: External jet-nebulizer flow can alter delivered volume, pressure, PEEP, triggering, and oxygen concentration, especially in a small patient. Use a ventilator-integrated or compensated setup when available and monitor the patient and measured ventilation during treatment.